Article
NN-800s: Brain-penetrant trimeric nanobodies enable potent TNFα inhibition via TfR1-mediated transcytosis
2026-04-30
Abstract excerpt
Tumor necrosis factor alpha (TNFα) is a central mediator of neuroinflammation and synaptic dysfunction in multiple central nervous system (CNS) disorders, including Alzheimer’s disease. Although clinically approved TNFα inhibitors are highly effective in peripheral inflammatory diseases, their therapeutic application in CNS disorders is severely limited by poor blood–brain barrier (BBB) penetration. Here, we repor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 96c3c3de-e68e-5bf3-867b-f40968f14c3b
- DOI
- 10.64898/2026.04.28.721316
